Search
Recent Posts
- BIOCORP obtains 510(k) FDA clearance for SoloSmart®, Sanofi’s smart cap for disposable insulin pens.
- BIOCORP will exhibit at PDA – Universe of Pre-Filled Syringes and Injection Devices Conference, in Gothenburg on October 16, 17, and 18
- BIOCORP reports half-year results as of June 30, 2023
- Completion of Novo Nordisk’s acquisition of a controlling stake in BIOCORP
- Signing of the definitive agreements in connection with the acquisition by NOVO NORDISK of a controlling stake in BIOCORP
Archives
- January 2024
- September 2023
- August 2023
- June 2023
- April 2023
- March 2023
- January 2023
- December 2022
- October 2022
- September 2022
- July 2022
- April 2022
- March 2022
- January 2022
- December 2021
- November 2021
- September 2021
- June 2021
- April 2021
- March 2021
- February 2021
- January 2021
- November 2020
- October 2020
- September 2020
- June 2020
- April 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- July 2019
- June 2019
- May 2019
- April 2019
- February 2019
- January 2019
- December 2018
- October 2018
- September 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- May 2017
- April 2017
- March 2017
- January 2017
- December 2016
- October 2016
- September 2016
- May 2016
- April 2016
- February 2016
- October 2015
- January 2015
Categories
- PR 2023
- Financial calendar 2023
- Financial calendar 2022
- Uncategorized
- PR 2022
- Non classé
- Financial calendar 2021
- PR 2021
- PR 2020
- Financial calendar 2020
- News
- Financial calendar 2019
- PR 2019
- PR 2018
- Financial calendar 2018
- PR 2017
- Regulated information
- Financial calendar 2017
- Letter to shareholders
- PR 2016
- PR 2015